PAOLINO, SABRINA
 Distribuzione geografica
Continente #
EU - Europa 8.549
Totale 8.549
Nazione #
IT - Italia 8.549
Totale 8.549
Città #
Genova 6.506
Rapallo 1.038
Genoa 958
Bordighera 47
Totale 8.549
Nome #
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 149
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 149
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 142
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 136
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 136
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 130
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 128
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 125
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 121
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 121
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 120
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 118
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 117
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 115
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 113
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 109
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 108
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 107
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 107
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 106
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 105
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 105
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 105
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 105
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 104
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 104
Vitamin D in rheumatoid arthritis. 103
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. 102
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 102
Vitamin D, steroid hormones, and autoimmunity. 101
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey 101
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 100
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 100
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 100
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 100
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 97
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 96
Systemic lupus erythematosus: state of the art on clinical practice guidelines 96
Correlation between bone quality and microvascular damage in systemic sclerosis patients 95
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 94
A method for counting monosodium urate crystals in synovial fluid 91
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 90
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 90
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 88
Anti-TNF and sex hormones 88
RHEUMATOID VERSUS PSORIATIC ARTHRITIS: SIMILAR OR DIFFERENT BONE LOSS? 87
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. 83
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 83
PLASMA VITAMIN D LEVELS IN RELATION TO INSULIN RESISTANCE AND RISK OF METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS PATIENTS 83
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 83
Advanced in naifold capillaroscopic analysis in systemic sclerosis 82
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 81
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. 81
Use of glucocorticoids and risk of infections. 80
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 80
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 79
Osteoporosis in the elderly. 79
Capillaroscopy 2016: new perspectives in systemic sclerosis. 78
New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review 77
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. 75
Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. 75
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 75
Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. 74
VITAMIN D SERUM LEVELS CORRELATE WITH BONE MASS VALUES IN POSTMENOPAUSAL SYSTEMIC SCLEROSIS PATIENTS 73
Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques. 73
Comment on: Lower urinary tract symptoms in systemic sclerosis patients: a detailed investigation: reply. 73
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 71
Are there any positive effects of TNF-alpha blockers on bone metabolism? 70
Vitamin D, inflammation and immunity: review of literature and considerations on recent translational and clinical research developments 70
Role of endothelin-1 on cell growth and fibrogenesis by primari cultures of human fibroblast: the effects of sex hormones 69
Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases 69
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 68
[Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis]. 65
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 63
Plasma cortisol and cholesterol differently correlate with disease activity in a pilot group of rheumatoid arthritis patients 61
Systemic sclerosis: markers and targeted treatments 58
The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: A systematic review. 58
Naifold capillaroscopy in rheumatology: ready for the daily use but with care in terminology 55
Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study. 55
Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis. 54
Effects of anti-TNFα treatment on lipid profile in patients with active rheumatoid arthrits 53
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. 53
The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients. 52
Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. 51
Influence of anti-TNF alpha treatment on insulin resistance in patients with active rheumatoid arthritis. 51
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis 49
The paradox of ankylosing spondylitis: Concomitant osteoporosis and new bone formation 48
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 48
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 48
Epigenetics, pregnancy and autoimmune rheumatic diseases. 48
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients 46
Assessment of the plantar pressure and its correlation with the disease progression in patients with rheumatoid arthritis | [Valutazione della pressione plantare e correlazione con l'attività di malattia nei pazienti con artrite reumatoide] 45
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients. 45
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines 44
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 41
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 39
Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study 37
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study 36
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study 35
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. 35
Totale 8.363
Categoria #
all - tutte 28.868
article - articoli 27.683
book - libri 0
conference - conferenze 1.025
curatela - curatele 0
other - altro 55
patent - brevetti 0
selected - selezionate 0
volume - volumi 105
Totale 57.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019347 0 0 0 0 0 0 0 0 0 0 175 172
2019/20202.698 139 67 87 156 221 334 346 227 251 455 343 72
2020/20211.111 60 104 126 106 83 88 53 93 84 130 83 101
2021/20221.422 60 69 83 164 39 97 111 332 111 122 70 164
2022/20231.282 144 93 27 90 196 173 21 105 207 25 175 26
2023/2024824 35 125 17 129 51 204 77 115 37 34 0 0
Totale 8.997